A carregar...

Drug withdrawal in women with progressive metastatic breast cancer while on aromatase inhibitor therapy

BACKGROUND: Acquiring resistance to endocrine therapy is common in metastatic hormone-receptor-positive breast cancer (MBC). These patients most often transition either to next-line endocrine therapy or to systemic chemotherapy. However, withdrawal of endocrine therapy and observation as is selectiv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Cancer
Main Authors: Chavarri-Guerra, Y, Higgins, M J, Szymonifka, J, Cigler, T, Liedke, P, Partridge, A, Ligibel, J, Come, S E, Finkelstein, D, Ryan, P D, Goss, P E
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4260029/
https://ncbi.nlm.nih.gov/pubmed/25233398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bjc.2014.502
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!